Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor
J Masuda, T Nabika, Y Notsu - Current opinion in neurology, 2001 - journals.lww.com
Silent stroke is frequently recognized in elderly persons. Diffusion-weighted magnetic
resonance imaging has proved to be highly sensitive in the detection of recent silent stroke …
resonance imaging has proved to be highly sensitive in the detection of recent silent stroke …
Effect of aspirin treatment on serum concentrations of lipoprotein (a) in patients with atherosclerotic diseases
M Akaike, H Azuma, A Kagawa, K Matsumoto… - Clinical …, 2002 - academic.oup.com
Background: Increased serum lipoprotein (a)[Lp (a)] is an independent risk factor for
atherosclerosis. We previously reported that aspirin reduced Lp (a) production by cultured …
atherosclerosis. We previously reported that aspirin reduced Lp (a) production by cultured …
Evaluation of genetic risk factors for silent brain infarction
Y Notsu, T Nabika, HY Park, J Masuda, S Kobayashi - Stroke, 1999 - Am Heart Assoc
Background and Purpose—Silent brain infarction (SBI) is often found with white matter
hyperintensity. A recent genetic study on elderly twins indicated that the susceptibility to …
hyperintensity. A recent genetic study on elderly twins indicated that the susceptibility to …
Apolipoprotein (a) gene polymorphism in the Korean population: is there any relevance to essential hypertension?
BY Kang, JS Bae, KT Kim, JH Kim, JH Shin… - Medical Principles and …, 2002 - karger.com
Objective: To investigate the role of the apolipoprotein (a)[Apo (a)] gene in predicting
essential hypertension in the Korean population, we undertook a case-control study using …
essential hypertension in the Korean population, we undertook a case-control study using …
The relationship among apolipoprotein (a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes …
P Beneš, J Mužík, J Benedik, V Znojil, J Vácha - Human biology, 2002 - JSTOR
Increased plasma concentration of lipoprotein (a)[Lp (a)] is an established independent risk
factor for coronary artery disease (CAD), which is strongly genetically determined. This study …
factor for coronary artery disease (CAD), which is strongly genetically determined. This study …
Polymorphisms in the apolipoprotein (a) gene, plasma Lp (a) and cardiovascular risk
P Beneš - Heart Drug, 2003 - karger.com
Increased plasma concentration of lipoprotein (a)[Lp (a)] represents an established risk
factor for coronary artery disease (CAD). The plasma Lp (a) level is relatively stable during …
factor for coronary artery disease (CAD). The plasma Lp (a) level is relatively stable during …
[图书][B] A Linkage Analysis Study of Genes Involved in Lipoprotein (a) Regulation and Their Relevance in the Decline of Renal Function
KA Latham - 2007 - search.proquest.com
Abstract Introduction: Serum Lipoprotein (a)[Lp (a)] is an independent risk factor for
atherothrombotic disease. High levels of Lp (a) are a clinical feature of nephrotic syndrome …
atherothrombotic disease. High levels of Lp (a) are a clinical feature of nephrotic syndrome …